Unknown

Dataset Information

0

C-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.


ABSTRACT: : c-MET pathway over-activation is the signature of malignancy acquisition or chemotherapy resistance of many cancers. We recently demonstrated that type II Testicular Germ Cell Tumours (TGCTs) express c-MET receptor. In particular, we elucidated that the non-seminoma lesions express c-MET protein at higher level, compared with the seminoma ones. In line with this observation, NTERA-2 clone D1 (NT2D1) non-seminoma cells increase their proliferation, migration and invasion in response to Hepatocyte Growth Factor (HGF). One of the well-known adaptor-proteins belonging to c-MET signaling cascade is c-Src. Activation of c-Src is related to the increase of aggressiveness of many cancers. For this reason, we focused on the role of c-Src in c-MET-triggered and HGF-dependent NT2D1 cell activities. In the present paper, we have elucidated that this adaptor-protein is involved in HGF-dependent NT2D1 cell proliferation, migration and invasion, since Src inhibitor-1 administration abrogates these responses. Despite these biological evidences western blot analyses have not revealed the increase of c-Src activation because of HGF administration. However, notably, immunofluorescence analyses revealed that cytoplasmic and membrane-associated localization of c-Src shifted to the nuclear compartment after HGF stimulation. These results shed new light in the modality of HGF-dependent c-Src recruitment, and put the basis for novel investigations on the relationship between c-Src, and TGCT aggressiveness.

SUBMITTER: Leonetti E 

PROVIDER: S-EPMC6358843 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.

Leonetti Erica E   Gesualdi Luisa L   Scheri Katia Corano KC   Dinicola Simona S   Fattore Luigi L   Masiello Maria Grazia MG   Cucina Alessandra A   Mancini Rita R   Bizzarri Mariano M   Ricci Giulia G   Catizone Angela A  

International journal of molecular sciences 20190114 2


<b>:</b> c-MET pathway over-activation is the signature of malignancy acquisition or chemotherapy resistance of many cancers. We recently demonstrated that type II Testicular Germ Cell Tumours (TGCTs) express c-MET receptor. In particular, we elucidated that the non-seminoma lesions express c-MET protein at higher level, compared with the seminoma ones. In line with this observation, NTERA-2 clone D1 (NT2D1) non-seminoma cells increase their proliferation, migration and invasion in response to H  ...[more]

Similar Datasets

| S-EPMC5769921 | biostudies-literature
| S-EPMC2172872 | biostudies-literature
| S-EPMC4522096 | biostudies-literature
| S-EPMC5977465 | biostudies-literature
| S-EPMC5752918 | biostudies-literature
| S-EPMC3261686 | biostudies-literature
| S-EPMC4317785 | biostudies-literature
| S-EPMC7698414 | biostudies-literature
| S-EPMC10273698 | biostudies-literature
| S-EPMC8613927 | biostudies-literature